A thorough understanding of the mechanism of Chk1-dependent checkpoint activation is critical for the development of anti-cancer strategies, as it is apparent that inactivating Chk1 can sensitize cells to genotoxic therapies [4], [5]. Here, CHEK1 is linked to cancer.